Prestigious Red Dot Award for Fisher & Paykel Healthcare's New Brevida Mask


Fisher & Paykel Healthcare has won a Red Dot Product Design Award for its F&P Brevida™ nasal pillows mask, used in the treatment of obstructive sleep apnea (OSA).

The Red Dot is one of the most competitive design competitions in the world, known internationally for recognising great design and innovation. This year, the product design category, in which the F&P Brevida was recognised, received submissions from 54 countries.

“This award is testament to the hard work and talent of our team,” said Chris Nightingale, General Manager - OSA. “We set out to design a mask that was extremely comfortable and easy for our patients to use. It was always about putting the patient at the centre of our design approach, and we think that really shows in the quality of the end result.”
 
Key technology in the F&P Brevida includes adjustable headgear for a good fit, a special AirPillow™ seal which inflates to form a pillow of air in and around the nose for a gentle, effective seal, and VisiBlue™ colour cues on key components to assist patients with daily use for simpler and more intuitive mask education.
 
The Red Dot Design Award was founded in Germany in 1955 and is a globally recognised forum for design excellence. This year, it was judged by an independent and international panel of 39, who assessed, tested and discussed each entry over a period of several days. Products were assessed according to criteria across innovation, formal quality, functionality and ecological compatibility.  
 
This accolade follows a Product Design award for the Brevida from iF International Forum Design GmbH in February 2017, and is the second time Fisher & Paykel Healthcare has won a Red Dot award, after also winning for the F&P Optiflow™ Junior nasal cannula range in 2013.
 
ENDS
 
 

 

About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Investors:

Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073

 

Media:

Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 (0) 21 713 911